Streetbeat News

Products Services

AUR

UBER

Aurora and Uber Freight are collaborating to democratize driverless trucks for carriers of all sizes. This initiative is part of their ongoing partnership to integrate and deploy autonomous trucks on the Uber Freight network.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:13 am

HOWL

Werewolf Therapeutics announced initial results from its Phase 1 trial of WTX-330 as a monotherapy for immunotherapy-insensitive or resistant locally advanced or metastatic solid tumors or non-Hodgkin lymphoma. Additional results are expected in Q4 of 2024.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:12 am

DLO

KCB Bank and dLocal have entered into a strategic partnership to expand global payments, with approval from the Central Bank of Kenya.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:09 am

QNCX

Quince Therapeutics has dosed the first patient in its Phase 3 clinical trial of EryDex for the treatment of Ataxia-Telangiectasia. This pivotal study is being conducted under a Special Protocol Assessment agreement with the U.S. FDA.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:09 am

QNCX

Quince Therapeutics has initiated the Phase 3 NEAT trial to evaluate the neurological effects of EryDex in patients with Ataxia-telangiectasia. The first patient has been dosed, and topline results are expected in the second half of 2025, with a potential New Drug Application submission in 2026.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:09 am

EVGN

Casterra Ag Ltd., a subsidiary of Evogene Ltd. (NASDAQ:EVGN), has received a $440K order for castor seeds from an existing customer, expanding its operations into a new African country. This order is part of a larger revenue expectation of $8.4 million for 2023 and 2024. The global biodiesel market is projected to grow significantly, and Casterra's high oil-yielding castor seeds are positioned to benefit from this trend.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:08 am

GNSS

Genasys Inc. (NASDAQ:GNSS) announced new and follow-on defense orders from the Middle East, with a combined value of over $2.7 million. The orders are part of a previously announced foreign military sales contract to deploy LRAD systems on shore installations and naval ships.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:07 am

BRKR

Cellens is collaborating with Bruker BioAFM, a unit of Bruker, to develop clinical diagnostic tests using multi-parametric, single-cell biophysical markers and machine learning. The technology has shown high sensitivity and specificity in detecting bladder cancer from urine samples in pilot studies.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:06 am

KVHI

KVH Industries has announced an expanded relationship with Starlink through a bulk data distribution agreement. This agreement allows KVH to develop and sell custom airtime plans using Starlink's mobile priority service. KVH has prepaid for a large block of Starlink data at favorable rates and added Starlink Standard flat-panel terminals to its product offerings.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:06 am

IONS

The FDA has accepted Ionis Pharmaceuticals' New Drug Application for Olezarsen, a treatment for Familial Chylomicronemia Syndrome, for priority review. The FDA action date is set for December 19.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:04 am